Trial intelligence / Profile preview

Propofol vs Ciprofol and Sufentanil vs Esketamine in Elderly ERCP Patients

NCT07584902Not yet recruiting

Start
Apr 2026
Primary completion
Oct 2026
Modality
Allosteric Modulators
01

Overview

Randomised trial of ciprofol and esketamine (4 arms). Primary endpoints: Incidence of hypoxemia and Incidence of hypotension. Planned start Apr 2026; status: not yet recruiting.

02

Drugs

ciprofolesketamine

Beyond the preview

Go deeper on NCT07584902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07584902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call